Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

BEZ-235

Inhibitor of PI3K and mTOR kinase activity
 
ENZ-CHM191-0050 50 mg 184.00 USD
Do you need bulk/larger quantities?
 
NVP-BEZ235 is an imidazo[4,5-c]quinoline derivative that inhibits PI3K and mTOR kinase activity by binding to the ATP-binding cleft of these enzymes. In cellular settings using human tumor cell lines, this molecule is able to effectively and specifically block the dysfunctional activation of the PI3K pathway, inducing G1 arrest at IC50 values of 3-10nM in biological cell growth and viability assays. In addition NVP-BEZ235 shows effective IC50 values in in vitro tests against mTOR and PI3K family members of 10nM.

Product Specification

Alternative Name:NVP-BEZ235, Dactolisib, 2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile
 
Formula:C30H23N5O
 
MW:469.5
 
CAS:915019-65-7
 
Purity:≥99% (HPLC)
 
Identity:Determined by EM-MS, NMR
 
Appearance:White powder.
 
Solubility:Soluble in DMSO (1mg/ml) or ethanol (1mg/ml).
 
Shipping:Ambient
 
Short Term Storage:+4°C
 
Long Term Storage:-20°C
 
ENZ-CHM191 structure
Please mouse over
ENZ-CHM191 structure

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
PI3 kinase
mTOR
By biological activity:
PI3 kinase Inhibitor
mTOR Inhibitor
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,